Lovastatin: World First Approval of Merck & Co.'s Hypolipaemic Agent in the USInpharma Weekly1987PDF135 KB
Trientine: World First Introduction of This Chelating Agent by Merck, Sharp and Dohme in the USAInPharma1986PDF71 KB
Asymmetric Synthesis of a Highly Soluble ‘trimeric’ Analogue of the Chiral Nematic Liquid Crystal Twist Agent Merck S1011Rego · Liquid Crystals2009PDF664 KB
The Pharmacy of Chlorothiazide (6-Chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide): A New Orally Effective Diuretic Agent**Merck Sharp & Dohme Research Laboratories, Division of Merck & Co., Inc., West Point, PaCharnicki · Journal of the American Pharmaceutical Association (Scientific ed )1959PDF376 KB
4454107 TC99M-Phenida, radioscintigraphic agent for diagnosis of hepatoniliary disease : Richard Rolleston, Dollard des Ormeaux, Canada assigned to Merck & Co IncInternational Journal of Nuclear Medicine and Biology1985PDF85 KB
Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction: J. Lynch, L. Heaney, A. Wallace, R. Stein. Department of Pharmacology, Merck, Sharp and Dohme Research Laboratories, West Point, Pennsylvania., U.S.AJournal of Molecular and Cellular Cardiology1989PDF105 KB